Business Context and Reporting Period
Company: Chicago Mercantile Exchange Holdings Inc. (CME Group Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2002
Business Overview: CME operates a derivatives exchange offering clearing, transaction, and data services. The company completed a reorganization into a holding company structure in December 2001. Revenue is primarily driven by trading volume, fee structures, and the mix of products traded (Interest Rate, Equity, Foreign Exchange, and Commodity).
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sep 30, 2002 | Nine Months Ended Sep 30, 2002 | Nine Months Ended Sep 30, 2001 |
|---|---|---|---|
| Total Revenues | $129,649 | $346,798 | $289,297 |
| Net Revenues | $125,165 | $333,789 | $282,197 |
| Net Income | $19,354 | $61,018 | $54,481 |
| Diluted EPS | $0.65 | $2.04 | $1.86 |
| Operating Cash Flow (9mo) | N/A | $101,566 | $77,427 |
| Cash & Equivalents (Sep 30, 2002) | $197,164 | ||
| Long-term Debt (Sep 30, 2002) | $3,232 | ||
| Shareholders' Equity (Sep 30, 2002) | $299,570 |
Note: Net Revenues are calculated after deducting securities lending interest expense from Total Revenues.
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 18.3% ($51.6 million) for the nine months ended September 30, 2002, compared to the same period in 2001. This was driven by a 40.0% increase in total trading volume (413.8 million contracts vs. 295.5 million).
- Profitability: Net income rose 12.0% to $61.0 million for the nine-month period. However, operating margins declined from 32.2% in 2001 to 30.3% in 2002 due to increased expenses.
- Expense Increases: Total expenses increased 21.6% ($41.3 million). The primary driver was a one-time $13.7 million expense for the settlement of the Wagner patent litigation. Excluding this settlement and stock-based compensation, operating expenses would have increased only 15.5%.
- Liquidity: Cash and cash equivalents increased significantly from $69.1 million at year-end 2001 to $197.2 million at September 30, 2002. This was largely due to a change in investment policy converting marketable securities to short-term cash equivalents.
- Trading Volume: Electronic trading (GLOBEX) volume surged 133.9% year-over-year, representing 31.8% of total volume in the first nine months of 2002.
Guidance, Outlook, Risks, and Unusual Items
- Unusual Items:
- Wagner Patent Litigation: Settled in August 2002 for $15.0 million ($5.0 million paid immediately, remainder in annual installments). The present value of $13.7 million was expensed in Q3 2002.
- Stock-Based Compensation: A non-cash expense of $5.7 million for the nine months ended September 30, 2002, primarily related to the CEO's stock option. This expense is subject to significant volatility based on the value of Class A shares and trading rights.
- Outlook & Dividends: Management intends to pay regular quarterly dividends beginning in Q1 2003, targeting approximately 20% of the prior year's cash earnings. A $0.60 per share dividend was paid in June 2002.
- Risks & Contingencies:
- Indemnification Dispute: CME is in a dispute with Euronext-Paris regarding indemnification for the Wagner patent litigation costs. CME has requested reimbursement of approximately $18.5 million; Euronext-Paris has disclaimed obligation and is seeking reimbursement of its own expenses.
- Market Risk: Interest rate risk is mitigated by a new investment policy limiting holdings to money market funds and U.S. Government securities with maturities of seven days or less. Foreign exchange trading risk (GFX) is hedged with offsetting positions.
- Liquidity Facility: A $500 million committed line of credit was renewed in October 2002 to cover potential clearing firm defaults or payment system disruptions.
Key Facts for Investor Verification
- Patent Settlement Impact: Verify the cash flow impact of the $5.0 million initial payment made in September 2002 and the schedule for the remaining $10.0 million in annual payments starting August 2003.
- Volume vs. Revenue Efficiency: While trading volume increased 40%, revenue per contract decreased from $0.717 to $0.632 due to volume discounts and fee limits. Verify if this trend persists as volume incentives are adjusted.
- Stock-Based Compensation Volatility: Confirm the methodology for valuing the CEO's stock option, as it creates significant non-cash expense volatility unrelated to operational performance.
- OneChicago Joint Venture: Monitor the financial performance of the OneChicago joint venture (40% ownership), which contributed a net loss to "Other Revenue" and has not yet initiated trading of single stock futures.
- Investment Policy Change: Verify the classification of the $128 million increase in cash equivalents resulting from the shift from marketable securities to short-term money market funds and U.S. Treasuries.